Acupuncture in Patients With Stable Angina Pectoris (ASAP)

Effect of Acupuncture in Patients With Stable Angina Pectoris: an Open Label, Randomized, Controlled,Multi-center Clinical Study

This trail aims to evaluate the efficacy of acupoints on the specific meridian for chronic stable angina pectoris, compared with acupoints on the other meridian, sham acupoints and waiting-list. And to confirm the specificity of acupoints on meridian.

Study Overview

Status

Completed

Conditions

Detailed Description

The basis of acupuncture is the theory of meridians and acupoints. Meridian and collaterals internally pertain to viscera, and externally spread over the extremities. An acupoint is the place where the visceral qi and meridian qi distributed in. besides acupoints are the stimulus points and reactive points for acupuncture to treat the diseases. Selecting the acupoints on the specific meridian is the basic principle of acupuncture. Recently, as to the existence of specificity of acupoints on the meridian has been questioned by many researchers. This trial using chronic stable angina pectoris as a carrier, select the acupoints on the hand shao yin heart meridian and hand jue yin pericardium meridian to treat chronic stable angina pectoris. Compared with acupoints on the other meridian and non-acupoints ,aiming to evaluate the efficacy, furthermore ,to confirm the existence of the specificity of acupoints on meridian.

Study Type

Interventional

Enrollment (Actual)

404

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610075
        • Chengdu University of Traditional Chinese Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

1.Meet the diagnostic criteria of ACC/AHA angina pectoris of coronary heart disease.

2.35 ≤ age ≤ 80 years of age, both male and female.

3.The onset of angina pectoris≥3 months, and the frequency of angina attack≥2 a week.

4.Patients signed the informed consent.

Exclusion Criteria:

  1. age≤35 or age≥80
  2. Pregnant women or women in lactation or women of child bearing potential plan to conceive in the recent six months.
  3. Combined with cardiovascular, digestive, respiratory, urinary, blood, nervous, endocrine system, severe primary disease clinical failed to effectively control the disease.
  4. Complicated with mental disorders.
  5. allergic constitution or bleeding disorder.
  6. Patients accompany with acute coronary syndrome (including acute myocardial infarction, unstable angina), severe arrhythmias ( severe atrioventricular block, ventricular tachycardia, heartbeat influence the flow dynamics in supraventricular tachycardia, heartbeat frequent premature beats especially premature ventricular contractions ), atrial fibrillation, primary cardiomyopathy, valvular heart disease.
  7. The blood pressure and blood glucose fail to meet the treatment targets.
  8. Cardiovascular disease who had been treated with acupuncture during the previous three months.
  9. Currently participating in other clinical trials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: acupoints on specific meridian
Acupuncture plus foundation treatment。 We Select specific acpupoints on the heart and pericardium meridian.
In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Other Names:
  • Electro-acupuncture,Massage

Each group in the basic treatment,Foundation treatment including health education and basic drug therapy.

We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.

Basic medication: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.

Other Names:
  • health education , basic drug therapy
Active Comparator: acupoints on the other meridian
Acupuncture plus foundation treatment。We choose the acupoints on the other meridian。
In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Other Names:
  • Electro-acupuncture,Massage

Each group in the basic treatment,Foundation treatment including health education and basic drug therapy.

We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.

Basic medication: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.

Other Names:
  • health education , basic drug therapy
Sham Comparator: sham acupoints
Acupuncture plus foundation treatment。We use sham acupoints。
In each session, we treat bilaterally, 3 times a week and 2 days off a week, each patient in the acupuncture treatment groups will receive 12 sessions of acupuncture treatment over 4 weeks. The whole study period is 20 weeks including 4-week baseline period,4-week treatment period, and 12-week follow-up period. we will investigate at 0 day,4week,8week,12week,16week after randomization。
Other Names:
  • Electro-acupuncture,Massage

Each group in the basic treatment,Foundation treatment including health education and basic drug therapy.

We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.

Basic medication: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.

Other Names:
  • health education , basic drug therapy
Other: waiting-list
wait for the treatment,Only basic treatment, We will not treat the participants until they complete all the observations.

Each group in the basic treatment,Foundation treatment including health education and basic drug therapy.

We recommend lifestyle modification for all patients. Modifications include increasing exercise; limiting alcohol consumption; and weight loss; quit smorking etc.

Basic medication: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.

Other Names:
  • health education , basic drug therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of angina attacks
Time Frame: 16 weeks after inclusion
The frequency of angina attack during 4-week.
16 weeks after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The severity of angina ( VAS score)
Time Frame: 0 day,4, 8, 12, 16 weeks after inclusion
The VAS score evaluation angina pain severity
0 day,4, 8, 12, 16 weeks after inclusion
The dosage of nitroglycerin
Time Frame: 0 day,4, 8, 12, 16 weeks after inclusion
0 day,4, 8, 12, 16 weeks after inclusion
Six minute walk test
Time Frame: 0 day and 4 weeks after inclusion
Six minute walk test in the evaluation of exercise tolerance
0 day and 4 weeks after inclusion
Dynamic ECG Observation of the changes of ST-T
Time Frame: 0 day and 4 weeks after inclusion
Dynamic electrocardiogram in six minute walk test to do
0 day and 4 weeks after inclusion
The Seattle Angina Questionnaire ( SAQ ) score
Time Frame: 0 day,4, 8, 12, 16 weeks after inclusion
0 day,4, 8, 12, 16 weeks after inclusion
self-rating anxiety scale
Time Frame: 0 day,4, 8, 16 weeks after inclusion
0 day,4, 8, 16 weeks after inclusion
The incidence of cardiovascular episode during the 4 months
Time Frame: 4, 8, 12, 16 weeks after inclusion
The incidence of cardiovascular episode during the 4 months(develop into unstable angina, acute myocardial infarction, death)
4, 8, 12, 16 weeks after inclusion
Self-rating Depression Scale
Time Frame: 0 day,4, 8, 16 weeks after inclusion
0 day,4, 8, 16 weeks after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: fan-rong liang, Professor, Chengdu University of Traditional Chinese Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2012

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

August 23, 2012

First Submitted That Met QC Criteria

September 12, 2012

First Posted (Estimate)

September 17, 2012

Study Record Updates

Last Update Posted (Actual)

February 17, 2020

Last Update Submitted That Met QC Criteria

February 13, 2020

Last Verified

February 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Angina, Stable

Clinical Trials on acupuncture

3
Subscribe